$CBIS The Company applauded legislators in seeking to improve access to cannabis for medical purposes, and the DEA for initiating a review on its scheduling of marijuana. Market could potentially open up approximately 10 - 100 times to well over US$300 Billion based on streamlined FDA clinical trials access and increased pre-clinical study acceptances.
https://finance.yahoo.com/news/cannabis-scien...42821.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!